An announcement from 180 Life Sciences (ATNF) is now available.
On March 7, 2024, 180 Life Sciences Corp. announced the resignation of Sir Marc Feldmann from its Board of Directors and the appointment of Omar Jimenez and Ryan L. Smith as new independent directors. Despite Feldmann’s resignation not being due to disagreements, the move is significant as it brings fresh expertise to the Board, with Jimenez poised as the audit committee financial expert, and Smith bringing valuable business and fundraising experience. Both appointees are set to serve until the 2024 Annual Meeting of Stockholders and will receive annual retainer fees, with options for cash and stock compensation. The Board also streamlined its committees by merging two into one, reinforcing the company’s strategic oversight.
For an in-depth examination of ATNF stock, go to TipRanks’ Stock Analysis page.
